House com­mit­tee to grill Ab­b­Vie CEO next month on sup­press­ing Hu­mi­ra com­pe­ti­tion

Ab­b­Vie CEO Richard Gon­za­lez will be in the hot seat on May 18, again de­fend­ing the com­pa­ny’s mam­moth block­buster drug Hu­mi­ra be­fore the House Over­sight Com­mit­tee as com­pe­ti­tion for the world’s best-sell­ing drug isn’t like­ly to hit Amer­i­can shores for about two years.

Over­sight Com­mit­tee Chair­woman Car­olyn Mal­oney (D-NY) has been ze­ro­ing in on Ab­b­Vie for months now, even threat­en­ing to is­sue a sub­poe­na last Sep­tem­ber for doc­u­ments as part of her com­mit­tee’s on­go­ing in­ves­ti­ga­tion in­to drug pric­ing prac­tices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER